Skip to main content
Clinical Trials/CTRI/2016/10/007381
CTRI/2016/10/007381Not yet recruitingPhase 4

â??Therapeutic Drug Monitoring of Phenytoin,Carbamazepine and Sodium Valproate in Patientswith Epilepsy by High Performance LiquidChromatography (HPLC) in A Tertiary Health CareTeaching Hospital: A Prospective ObservationalStudyâ??

Department of Pharmacology Government Medical College Bhavnagar0 sites105 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
105

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Patients of any age and both gender who are willing to give written inform consent.
  • In case of patients less than 18 years of age guardian must be there to provide written inform consent.
  • Patients on Anti-Epileptic treatment with Phenytoin, Carbamazepine or Sodium valproate and in combination therapy with any of these or other Anti-Epileptic drugs for six months or more.

Exclusion Criteria

  • Patients on Anti-Epileptic Drugs for less than six months.
  • Patients on these drugs for indication other than Epilepsy.
  • Patients with history of hepatitis-B OR hepatitis-C
  • Patient who do not give consent.

Investigators

Sponsor
Department of Pharmacology Government Medical College Bhavnagar

Similar Trials